Jonathan Gootenberg is a prominent figure in the field of CRISPR research, focusing on the development of innovative diagnostic and therapeutic tools. With a Doctor of Philosophy degree in Systems Biology from Harvard University, he has also earned a Bachelor's degree in Biological Engineering and Mathematics from the prestigious Massachusetts Institute of Technology (MIT). Gootenberg has served as a McGovern Fellow at MIT and a Graduate Student at the Broad Institute of MIT and Harvard, helping to found Sherlock Biosciences.

Gootenberg's expertise lies in the development of CRISPR-based molecular diagnostic technologies, with an emphasis on the treatment of genetic disorders and infectious diseases. He has made significant contributions to the advancement of CRISPR technology, particularly for use in the diagnosis of RNA-based viruses. His research interests include the study of CRISPR-Cas systems, the design of CRISPR-based diagnostics, and the development of new RNA-targeting enzymes.